Is VERACYTE, INC. (VCYT) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1.5% / 30% | 15.4% / 30% | 1.7% / 30% | 2.46% / 5% | ✓ HALAL |
| DJIM | 1.5% / 33% | 15.4% / 33% | 1.7% / 33% | 2.46% / 5% | ✓ HALAL |
| MSCI | 2.8% / 33% | 29.4% / 33% | 3.2% / 33% | 2.46% / 5% | ✓ HALAL |
| S&P | 1.5% / 33% | 15.4% / 33% | 1.7% / 33% | 2.46% / 5% | ✓ HALAL |
| FTSE | 2.8% / 33% | 29.4% / 33% | 3.2% / 50% | 2.46% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 72.2% | |
| Operating Margin | 17.5% | |
| Net Margin | 12.8% | |
| Return on Equity (ROE) | 5.3% | |
| Return on Assets (ROA) | 2.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $136M |
| Free Cash Flow | $127M |
| Total Debt | $40M |
| Debt-to-Equity | 3.0 |
| Current Ratio | 8.1 |
| Total Assets | $1.4B |
Price & Trading
| Last Close | $32.80 |
| 50-Day MA | $36.08 |
| 200-Day MA | $34.80 |
| Avg Volume | 877K |
| Beta | 2.0 |
|
52-Week Range
$22.61
| |
About VERACYTE, INC. (VCYT)
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Purification Calculator
As a halal stock with 2.46% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is VERACYTE, INC. (VCYT) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), VERACYTE, INC. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is VERACYTE, INC.'s debt ratio?
VERACYTE, INC.'s debt ratio is 1.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 2.8%.
Does VERACYTE, INC. require dividend purification?
Yes, VERACYTE, INC. has an impermissible income ratio of 2.46%, which means 2.46% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are VERACYTE, INC.'s key financial metrics?
VERACYTE, INC. has a market capitalization of $2.4B, trailing P/E ratio of 36.6, and revenue of $517M. The company maintains a gross margin of 72.2% and a net margin of 12.8%. Return on equity stands at 5.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.